Association between rectal spacer use and bowel, urinary, and sexual dysfunction following prostate cancer brachytherapy: U.S. claims data analysis
Open Access
- 14 December 2025
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 25 (2) , 402-409
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
This publication has 43 references indexed in Scilit:
- Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing RadiotherapyJAMA Network Open, 2025
- Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementBrachytherapy, 2021
- PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot studyBrachytherapy, 2021
- HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysisBrachytherapy, 2021
- Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on techniqueWorld Journal of Urology, 2020
- Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate CancerJAMA Network Open, 2020
- Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantationBrachytherapy, 2020
- Optimization of prostate brachytherapy techniques with polyethylene glycol–based hydrogel spacers: A systematic reviewBrachytherapy, 2020
- Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trialBrachytherapy, 2017
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987